Lauren DAngelo
Chief Operating Officer presso ALPHA COGNITION INC.
Posizioni attive di Lauren DAngelo
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALPHA COGNITION INC. | Chief Operating Officer | 01/01/2023 | - |
Corporate Officer/Principal | 04/05/2021 | - |
Storia della carriera di Lauren DAngelo
Precedenti posizioni note di Lauren DAngelo
Società | Posizione | Inizio | Fine |
---|---|---|---|
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Sales & Marketing | - | - |
Formazione di Lauren DAngelo
Florida State University | Undergraduate Degree |
University of Florida | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Canada | 2 |
Posizioni
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Sales & Marketing | 1 |
Settori
Consumer Services | 3 |
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ALPHA COGNITION INC. | Health Technology |
Aziende private | 1 |
---|---|
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Health Technology |
- Borsa valori
- Insiders
- Lauren DAngelo
- Esperienza